Skip to main content
DNA Labs India

VRK1 Gene Pontocerebellar hypoplasia type 1A NGS Genetic Test

DNA Labs India | ISO 9001:2015 Certified

VRK1 Gene Pontocerebellar hypoplasia type 1A NGS Genetic Test

Short Name: VRK1 PCH1A NGS

Also known as: VRK1 Gene Next-Generation Sequencing Test, PCH1A Genetic Test, VRK1 Mutation Analysis Test

VRK1 Gene Pontocerebellar hypoplasia type 1A NGS Genetic Test test available at DNA Labs India for ₹20,000. Uses Next-Generation Sequencing (NGS) on Blood or Extracted DNA or One drop Blood on FTA Card samples. Results in Reports are generated within 3 to 4 weeks after the sample is received at the laboratory.. Free home collection in 300+ cities across India.

NGS Genetic Test🏠 Home Collection

🩺 Medically Reviewed By

Overview

The purpose of this single-gene NGS test is to detect mutations in the VRK1 gene that are known to cause pontocerebellar hypoplasia type 1A. It may be used to confirm a clinical diagnosis, offer recurrence-risk information for parents, identify at-risk family members, and support future family planning decisions. Clinical correlation and genetic counselling are essential.

Test Code
4474
Price
₹20,000
Sample Type
Blood or Extracted DNA or One drop Blood on FTA Card
Result Time
Reports are generated within 3 to 4 weeks after the sample is received at the laboratory.
Fasting Required
No
Method
Next-Generation Sequencing (NGS)
Step 1

Sample Collection

No special preparation or fasting is required. A genetic counselling session to draw a pedigree chart of family members affected with VRK1-related PCH1A disease is recommended. Please bring any relevant clinical records, imaging reports, or family history documents.

Method: Peripheral venipuncture / Dried blood spot on FTA card

Step 2

Laboratory Analysis

Depending on the sample type chosen, a trained phlebotomist will collect venous blood in an EDTA tube or prepare a dried blood spot on an FTA card. The procedure takes only a few minutes and is minimally invasive.

Step 3

Report Delivery

For blood samples, the tube should be gently inverted and transported at room temperature or refrigerated. For FTA cards, the card must be air-dried before placing it in the provided pouch. The sample will be transported to the laboratory under temperature-controlled conditions.

Timeline: Reports are generated within 3 to 4 weeks after the sample is received at the laboratory.

Patient Instructions

1
Before the Test:No special preparation is required. Clinical records and genetic counselling are recommended before the test.
2
During the Test:A blood sample may be collected from the arm, or a heel/finger prick may be used to prepare an FTA card sample. The procedure is quick and associated with minimal discomfort.
3
After the Test:There are no activity restrictions after sample collection. Reports are prepared in 3-4 weeks and shared via the patient portal, email, and WhatsApp along with raw data files.

About This Test

Who Should Get This Test

The purpose of this single-gene NGS test is to detect mutations in the VRK1 gene that are known to cause pontocerebellar hypoplasia type 1A. It may be used to confirm a clinical diagnosis, offer recurrence-risk information for parents, identify at-risk family members, and support future family planning decisions. Clinical correlation and genetic counselling are essential.

How to Prepare

  • No fasting is required before sample collection
  • Use an EDTA vacutainer for whole blood collection
  • For FTA card collection, apply one drop of blood directly onto the marked circle
  • The FTA card should not be refrigerated or frozen
  • Label the sample tube or card clearly with the patient's full name and date of birth

Doctor's Notes

Reviewed by — MBBS, MD (Medical Genetics) · Reg. No. 8532

"A confirmed genetic diagnosis can guide recurrence risk counselling and family planning options for affected families."

Last medically reviewed: September 7, 2026

Test Parameters & Specifications

Sample TypeBlood or Extracted DNA or One drop Blood on FTA Card
Sample Volume2-3 mL whole blood / 1 FTA card spot / extracted DNA sample
ContainerEDTA vacutainer / FTA card / sterile microcentrifuge tube
Collection MethodPeripheral venipuncture / Dried blood spot on FTA card

Sample Stability

Store at 2-8°C
Room temperature in a dry place
Store at -20°C or below
Sample Rejection Criteria:
  • Clotted or haemolysed blood sample
  • Frozen whole blood sample
  • FTA card that is wet, damaged, or contaminated
  • Unlabelled or mislabelled sample

Understanding Your Results

The interpretation of the VRK1 NGS genetic test is based on the latest ACMG/AMP guidelines for variant classification. Variants are reported as pathogenic, likely pathogenic, variants of uncertain significance, likely benign, or benign. A clinical geneticist reviews all results before issuing the final report.
📊

Suggests the variant is disease-causing and is consistent with PCH1A if clinical features are present.

📊

The variant cannot be clearly classified at this time; additional family testing may help clarify its significance.

📊

The variant is not considered to be disease-causing.

📊

No clinically significant VRK1 mutation was identified; other genetic causes should be considered.

⚠️ When to Consult a Doctor:

Consult a neurologist or clinical geneticist if your child presents with hypotonia, poor feeding, seizures, developmental delay, or MRI findings of pontocerebellar hypoplasia. If a positive or uncertain result is reported, genetic counselling is strongly recommended to understand recurrence risks, carrier status, and next steps.

Limitations

  • NGS may not detect large structural rearrangements, deep intronic variants, or trinucleotide repeat expansions
  • This single-gene test does not analyse other genes that can cause pontocerebellar hypoplasia or similar phenotypes
  • Variants of uncertain significance may be detected and may require additional family studies
  • The result should always be interpreted by a clinical geneticist with the patient's full medical history

Risks & Considerations

  • Minimal risk of bruising or bleeding at the venipuncture site
  • Rare possibility of infection at the needle site
  • Mild discomfort during sample collection
  • No significant physical risk for FTA card sampling

Interfering Factors

  • Poor or degraded DNA quality
  • Maternal cell contamination in blood samples from infants
  • Sample mix-up or mislabelling
  • Excessively haemolysed blood may affect DNA extraction

Compare With Similar Tests

TestVRK1 Gene Pontocerebellar hypoplasia type 1A NGS Genetic Test
ComparisonVRK1 Gene Pontocerebellar hypoplasia type 1A NGS Genetic Test
Worried about the process? Our certified phlebotomists collect thousands of samples every month across India. The process takes under 5 minutes and is virtually painless. Questions? Message us on WhatsApp — we're here 7 days a week.

Related Tests

For Hospitals & Clinics

Reference Laboratory Services

We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.

LIMS Integration

Your Data Privacy

Your medical data is protected under Indian law.

Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.

DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.

Book Your Test

Enter your details and we'll connect you within 15 minutes.

🧬

Quick Connect

Enter your mobile number and we’ll connect you with the team.

+91

✅ Connecting you now...

🔒 Your number is used to respond to this request.